ArticleJournal of the International AIDS Society2026

Modelling the 5-Year Impact of Twice-Yearly Injectable Lenacapavir for HIV Pre-Exposure Prophylaxis in the United States.

Mia Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.